Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin.

Autor:	Yamada Y; Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science Mie 513-8670 Japan., Iemura J; Department of Cardiovascular Surgery, Okanami General Hospital Mie 518-0121 Japan., Kambara A; Department of Cardiovascular Surgery, Okanami General Hospital Mie 518-0121 Japan., Tateishi N; Division of Clinical Engineering, Okanami General Hospital Mie 518-0121 Japan., Kozaki Y; Division of Clinical Engineering, Okanami General Hospital Mie 518-0121 Japan., Yamada M; Department of Clinical Engineering, Mie University Hospital Mie 514-0001 Japan., Maruyama J; Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science Mie 513-8670 Japan., Azuma E; Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science Mie 513-8670 Japan.
Jazyk:	angličtina
Zdroj:	The journal of extra-corporeal technology [J Extra Corpor Technol] 2023 Mar 24; Vol. 55 (1), pp. 23-29. Date of Electronic Publication: 2023 Mar 24 (Print Publication: 2023).
DOI:	10.1051/ject/2023003
Abstrakt:	Background : Postoperative atrial fibrillation (POAF) is defined as new-onset AF in the immediate postoperative period. The relatively high incidence of POAF after cardiac surgery is well described, but pathophysiological mechanisms underlying the initiation, maintenance, and progression of POAF may be multifactorial and have not yet been comprehensively characterized. One of the mechanisms includes altered Ca 2+ kinetics. Accumulating evidence has suggested that altered atrial cytosolic calcium handling contributes to the development of POAF, protamine reversibly modulates the calcium release channel/ryanodine receptor 2 (RyR2) and voltage-dependent cardiac RyR2. However, it is currently unknown whether such abnormalities contribute to the arrhythmogenic substrate predisposing patients to the development of POAF. Methods : We have retrospectively analyzed 147 patients who underwent cardiac surgery with cardiopulmonary bypass support. Of these, 40 patients were excluded from the analysis because of pre-existing AF. All patients received heparin followed by protamine at different dosing ratios of protamine-to-heparin, depending on the periods studied. Results : The dosing ratio of protamine-to-heparin = 1.0 was compared with higher dosing ratios of protamine-to-heparin >1.0 up to 1.7. POAF developed in 15 patients (15/107 = 14%), of these, 5 out of 57 patients (33.3%) in the dosing ratio of protamine-to-heparin = 1.0 and 10 out of 35 patients (66.7%) in the higher dosing ratios of protamine-to-heparin. Statistical significance was observed in patients with higher dosing ratios of protamine-to-heparin, compared with the dosing ratio of protamine-to-heparin = 1.0 (odds ratio = 3.890, 95% CI = 1.130-13.300, p -value = 0.031). When types of diseases were analyzed in terms of higher dosing ratios of protamine-to-heparin, only valvular disorders were significantly associated with POAF ( p  = 0.04). Conclusions : Protamine is clinically utilized to reverse heparin overdose and has been shown to display immunological and inflammatory alterations. However, its association with POAF has not been reported. Our results provide evidence that higher dosing ratios of protamine-to-heparin may increase the incidence of POAF. Competing Interests: Authors declared no conflict of interest. (© The Author(s), published by EDP Sciences, 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu